Search results for: tubulin-binding-agents

Tubulin Binding Agents

Author : Teresa Carlomagno
File Size : 84.55 MB
Format : PDF
Download : 521
Read : 372
Download »
This series presents critical reviews of the present position and future trends in modern chemical research. It contains short and concise reports on chemistry, each written by the world renowned experts.

Some Effects of Tubulin Binding Agents on Behaviour

Author : G. Clingbine
File Size : 46.10 MB
Format : PDF, ePub
Download : 780
Read : 320
Download »

Evaluation of Tubulin Binding Agents Alone in Combination for the Treatment of Melanoma and Other Solid Cancers

Author : Ashraf Sa Ta Azzabi
File Size : 42.18 MB
Format : PDF, Kindle
Download : 192
Read : 919
Download »

The Pursuit of Tubulin binding Agents

Author : Vicki Chang
File Size : 59.50 MB
Format : PDF, Docs
Download : 222
Read : 875
Download »
Presented here are two bodies of work regarding the synthesis of molecules related to tubulin-binding agents. Described in Chapter 1 is the synthesis of a library of biosynthetically-inspired colchicine-related compounds and the data regarding their biological activity. This chapter discusses using a pair of oxidative coupling reagents to generate molecular diversity in hopes of creating highly bioactive molecules. Described in Chapter 2 is the progress towards the synthesis of fluorinated epothilone B sulfonamide analogs. This chapter delineates approaches taken during the pursuit of a pair of analogs desired for biological testing. As the title alludes, the original compounds of colchicine and the epothilones are tubulin-binding agents, and it is this quality that affords them their highly desired biological activity as anticancer agents.

Design and Synthesis of Tubulin binding Agents and Their Incorporation Into Novel Dual acting Hybrid Molecules Targeting the Tumour Vasculature

Author : Adrian Coogan
File Size : 55.29 MB
Format : PDF, Mobi
Download : 786
Read : 1200
Download »

Drug Sensitivity Profiles in Neuroblastoma Cells with Acquired Resistance to Stabilising Tubulin Binding Agents

Author : Deborah Ifeoluwa Kajewole
File Size : 85.94 MB
Format : PDF, Mobi
Download : 830
Read : 563
Download »

Vascular Disruptive Agents for the Treatment of Cancer

Author : Tim Meyer
File Size : 66.32 MB
Format : PDF, ePub
Download : 649
Read : 822
Download »
Angiogenesis (formation of new vessels from pre-existing ones) is a crucial early event in the process of tumor development. New vessels supply the tumor with nutrients that are needed for further local growth and enable distant metastases (Folkman 1995). Judah Folkman (1971) highlighted the potential therapeutic imp- cations of tumor angiogenesis. He hypothesized that if tumor angiogenesis is inhibited, then tumor growth and metastasis will be impaired greatly or even impossible. The subsequent quest for endogenous and exogenous inhibitors of angiogenesis has yielded a variety of promising therapeutic agents that block one or more angiogenic pathways, a few of which have been approved by the FDA (e. g. , bevacizumab, sorafenib, sunitinib) for use as single agents or in combination with chemotherapy in specific populations of cancer patients (Sessa et al. 2008). There has also been a dramatic expansion in the exploration of novel anti-angiogenic agents pre-clinically and in clinical trials (Ferrara 2002). Some of the most promising data comes from the development of agents that inhibit one of the key growth factors involved in tumor angiogenesis – vascular endothelial growth factor (VEGF) (Ferrara et al. 2003). Bevacizumab is a monoclonal antibody against VEGF that was the first an- angiogenic agent that improved significantly the overall survival of patients with colorectal and non-squamous non-small cell lung cancer (Ferrara et al. 2005). Various agents that target tumor angiogenesis are currently under investigation in different cancer types in many clinical trials (Ferrara and Kerbel 2005).

Anticancer Agents from Natural Products Second Edition

Author : Gordon M. Cragg
File Size : 37.93 MB
Format : PDF, ePub
Download : 723
Read : 163
Download »
The approach to drug discovery from natural sources has yielded many important new pharmaceuticals inaccessible by other routes. In many cases the isolated natural product may not be an effective drug for any of several reasons, but it nevertheless may become a drug through chemical modification or have a novel pharmacophore for future drug design. In summarizing the status of natural products as cancer chemotherapeutics, Anticancer Agents from Natural Products, Second Edition covers the: History of each covered drug—a discussion of its mechanism on action, medicinal chemistry, synthesis, and clinical applications Potential for novel drug discovery through the use of genome mining as well as future developments in anticancer drug discovery Important biosynthetic approaches to "unnatural" natural products Anticancer Agents from Natural Products, Second Edition discusses how complex target-oriented synthesis—enabled by historic advances in methodology—has enormously expanded the scope of the possible. This book covers the current clinically used anticancer agents that are either natural products or are clearly derived from natural product leads. It also reviews drug candidates currently in clinical development since many of these will be clinically used drugs in the future. Examples include the drugs etoposide and teniposide derived from the lead compound podophyllotoxin; numerous analogs derived from taxol; topotecan, derived from camptothecin; and the synthetic clinical candidates, E7389 and HTI-286, developed from the marine leads, halichondrin B and hemiasterlin.

Encyclopedia of Cancer

Author : Manfred Schwab
File Size : 51.6 MB
Format : PDF, ePub, Docs
Download : 557
Read : 916
Download »
The merging of different basic and clinical science disciplines towards the common goal of fighting against cancer has long ago called for the establishment of a comprehensive reference source both as a tool to close the language gap between clinical and basic science investigators and as a platform of information for students and informed laymen alike. The Encyclopedia of Cancer provides rapid access to focused information on all topics of cancer research for clinicians, research scientists and advanced students. Given the overwhelming success of the Second Edition, which appeared in 2009, and fast recent development in the different fields of cancer research, it has been decided to publish a third fully revised and expanded edition, following the principal concept of the first edition that has proven so successful. Recent developments are seeing a dynamic progress in basic and clinical cancer science, with translational research increasingly becoming a new paradigm in cancer research. In particular, new approaches to both Personalized Cancer Medicine and Targeted Therapies have made promising progress. While the Second Edition featured scholarly contributions from approximately 1.000 scientists/clinicians in four Volumes, the Third Edition includes 1.300 contributors in 7 Volumes with an A-Z format of approx. 7000 entries. It provides definitions of common acronyms and short definitions of related terms and processes in the form of keyword entries. In addition, there are detailed essays, which provide comprehensive information on syndromes, genes and molecules, and processes and methods. Each essay is well-structured, with extensive cross-referencing between all entries. In the Third Edition, topical Essays present a comprehensive picture of major cancers, such as Breast Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Renal Cancer, Lung Cancer, and Hematological Maligancies, Leukemias and Lymphomas. For each of these cancers, different authoritative Essays are included that cover topics ranging from Pathology, to Clinical Oncology and Targeted Therapies. This new feature should meet the expectance that a wide community has towards a major cancer reference works. The Encyclopedia of Cancer will be accessible both in print and online, and this information source should be of value to both the clinical and basic scientific community as well as to the public.

Annual Reports in Medicinal Chemistry

Author :
File Size : 45.59 MB
Format : PDF
Download : 119
Read : 259
Download »
Annual Reports in Medicinal Chemistry